The number of people with susceptibility test result for rifampicin in Brazil
Brazil: The number of people with susceptibility test result for rifampicin was 50.47 in 2021. ▲ Rising
Latest (2021)
50.47
Change on year
down 5.6%
World rank
114th
of 146 countries
All-time high
53.45
in 2020
All-time low
33.89
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Brazil, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Brazil stood at 50.47.
The figure is down 5.6% on the previous year and up 48.9% over five years.
That places Brazil 114th out of 146 countries with data for 2021, putting it in the bottom quarter.
The number of people with susceptibility test result for rifampicin in Brazil, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 33.89 | — |
| 2018 | 41.5 | +22.4% |
| 2019 | 49.82 | +20.1% |
| 2020 | 53.45 | +7.3% |
| 2021 | 50.47 | -5.6% |
Brazil compared with similar countries
- Brazil's 50.47 is below the median for upper middle income countries, which is 92.7, 54% of the median. (45 countries reporting)
- Brazil's 50.47 is below the median for Latin America & Caribbean, which is 59.38, 85% of the median. (21 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 41.74 | 33.89 | 49.82 | 3 |
| 2020s | 51.96 | 50.47 | 53.45 | 2 |
Countries ranked near Brazil
- 111 Côte d'Ivoire 59.19 compare
- 112 Portugal 54.52 compare
- 113 Equatorial Guinea 54.36 compare
- 115 Bulgaria 47.71 compare
- 116 Iran, Islamic Republic of 46.76 compare
- 117 Nicaragua 46.72 compare
More health data for Brazil
- Un projection of annual infant deaths, annual growth rate -1.86 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.1539 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,496 deaths per 1,000 people (2090)
- Number of infants who die before age 1 3,476 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -1.66 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0296 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.63 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Brazil?
- The number of people with susceptibility test result for rifampicin in Brazil was 50.47 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Brazil?
- The highest recorded value was 53.45 in 2020.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Brazil?
- The lowest recorded value was 33.89 in 2017.
- How does Brazil rank for the number of people with susceptibility test result for rifampicin?
- Brazil ranks 114th out of 146 countries with data for 2021.
- Where does this Brazil data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).